Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Biochemical Pharmacology

• Publication date

  1986-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-2952(86)90677-5PMID 3778510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that the antiestrogen binding site is a histamine or histamine-like receptor.

  1985cited by this paper
• Steroidal and non steroidal antiestrogens in breast cancer cells in culture

  1984cited by this paper
• High affinity cytosol binding site(s) for antiestrogens in two human breast cancer cell lines and in biopsy specimens devoid of estrogen receptors.

  1984cited by this paper
• Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen.

  1984cited by this paper
• Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene.

  1984cited by this paper
• Interaction of non-steroidal antiestrogens with dopamine receptor binding.

  1984cited by this paper
• Steroidal and nonsteroidal antiestrogens in breast cancer cells in culture.

  1984cited by this paper
• Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.

  1984cited by this paper
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.

  1984cited by this paper
• Influence of tamoxifen and its N-desmethyl and 4-hydroxy metabolites on rat liver microsomal enzymes.

  1984cited by this paper
• Physicochemical and genetic evidence for specific antiestrogen binding sites.

  1983cited by this paper
• Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.

  1983cited by this paper
• Modulation of tamoxifen-specific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig.

  1983cited by this paper
• Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.

  1983cited by this paper
• Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.

  1983cited by this paper
• An antiestrogen-binding protein in human tissues.

  1983cited by this paper
• Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.

  1982cited by this paper
• Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum.

  1981cited by this paper
• The binding of tamoxifen to human mammary carcinoma cytosol.

  1980cited by this paper
• High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

  1980cited by this paper
• Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.

  1980cited by this paper
• Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosol.

  1980cited by this paper
• Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.

  1978cited by this paper
• Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents.

  1978cited by this paper
• Tamoxifen in advanced breast cancer.

  1978cited by this paper
• An improved assay for nuclear estrogen receptor in experimental and human breast cancer.

  1977cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Isolation of pure and unaltered liver nuclei morphology and biochemical composition.

  1956cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• AEBS inhibition in macrophages: Augmenting reality for SERMs repurposing against infections.

  2024cites this paper
• Binding Site Activity Estrogen : Possible Mediation by Excessive Antiestrogen Resistance to Tamoxifen with Persisting Sensitivity to Updated Version

  2006cites this paper
• Membrane associated estrogen receptors and related proteins: Localization at the plasma membrane and the endoplasmic reticulum

  2003cites this paper
• Estrogens, Progestins, and Their Antagonists

  1997cites this paper
• Antiestrogen Resistance in Human Breast Cancer

  1997cites this paper
• Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.

  1992cites this paper
• Synthesis and biological behavior of a boronated analogue of the antiestrogen U 23,469-M.

  1991cites this paper
• Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.

  1989cites this paper
• Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.

  1989cites this paper